Hormones and the stressed brain

Annals of the New York Academy of Sciences

Volumn 1018, Issue , 2004, Pages 1-15

  De Kloet, E Ronald ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Behavior; Brain; Corticosteroids; Genes; Receptors; Stress

Indexed keywords

CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN RECEPTOR; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

BINDING AFFINITY; BRAIN; CHINESE MEDICINE; COGNITION; CONFERENCE PAPER; CORRELATION ANALYSIS; DEPRESSION; EMOTION; ENERGY CONSERVATION; ENVIRONMENT; EXPERIENCE; GENETIC TRANSCRIPTION; HEREDITY; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; MOLECULAR MECHANICS; NERVE CELL; NEUROENDOCRINOLOGY; NONHUMAN; REGULATORY MECHANISM; STRESS; TRANSCRIPTION INITIATION;

RODENTIA;

EID: 3242723066     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1296.001     Document Type: Conference Paper

References (84)

1. SABBAN, E.L. & R. KVETŇANSKÝ. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci. 24: 91-98.
2. HEIM, C., U. EHLERT & D.H. HELLHAMMER. 2000. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25: 1-35.
3. SELYE, H. 1952. The Story of the Adaptation Syndrome. Acta, Montreal.
4. SAPOLSKY, R.M., L.M. ROMERO & A.U. MUNCK. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21: 55-89.
5. BELANOFF, J.K., M. KALEHZAN, B. SUND, et al. 2001. Cortisol activity and cognitive changes in psychotic major depression. Am. J. Psych. 158: 1612-1616.
6. HOLSBOER, F. 2001. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disorders 62: 77-91.
7. GOLD, P.W. & G.P. CHROUSOS. 1999. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc. Assoc. Am. Physicians 111: 22-34.
8. SCHATZBERG, A.F., A.J. ROTHSCHILD, P.J. LANGLAIS, et al. 1985. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiatr. Res. 19: 57-64.
9. BELANOFF, J.K., A.J. ROTHSCHILD, F. CASSIDY, et al. 2002. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol. Psych. 52: 386-392.
10. VAN DER LELY, A.J., K. FOEKEN, R.C. VAN DER MAST, et al. 1991. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann. Intern. Med. 114: 143-144.
11. MCEWEN, B.S., J.M. WEISS & L.S. SCHWARTZ. 1968. Selective retention of corticosterone by limbic structures in rat brain. Nature 220: 911-912.
12. DE KLOET, E.R., G. WALLACH & B.S. MCEWEN. 1975. Difference in binding of corticosterone and dexamethasone to rat brain and pituitary. Endocrinology 96: 598-609.
13. MEIJER, O.C., E.C.M. DE LANGE, D.D. BREIMER, et al. 1998. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdrlA P-glycoprotein knockout mice. Endocrinology 139: 1789-1793.
14. KARSSEN, A.M., O.C. MEIJER, I.C. VAN DER SANDT, et al. 2001. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142: 2686-2694.
15. REUL, J.M. & E.R. DE KLOET. 1985. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511.
16. EVANS, R.M. & J.L. ARRIZA. 1989. A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron 2: 1105-1112.
17. FUXE, K., A.C. WIKSTRÖM, S. ÖKRET, et al. 1985. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 117: 1803-1812.
18. VAN EEKELEN, J.A., W. JIANG, E.R. DE KLOET, et al. 1988. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J. Neurosci. Res. 21: 88-94.
19. ITO, T., N. MORITA, M. NISHI, et al. 2000. In vitro and in vivo immunocytochemistry for the distribution of mineralocorticoid receptor with the use of specific antibody. Neurosci. Res. 37: 173-182.
20. VAN STEENSEL, B., E.P. VAN BINNENDIJK, C.D. HORNSBY, et al. 1996. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J. Cell. Sci. 109: 787-792.
21. HELM, K.A., J.S. HAN & M. GALLAGHER. 2002. Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor mRNA expression in hippocampus and medial prefrontal cortex of the rat. Neuroscience 115: 765-774.
22. EDWARDS, C.R.W., P.M. STEWART, D. BURT, et al. 1988. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989.
23. SECKL, J.R., J. YAU & M. HOLMES. 2002. 11Beta-hydroxysteroid dehydrogenases: a novel control of glucocorticoid action in the brain. Endocr. Res. 28: 701-707.
24. AUPHAN, N., J.A. DIDONATO, C. ROSETTE, et al. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of I kappa B synthesis. Science 270: 286-290.
25. TAUSK, M. 1951. Das Hormon: Hat die Nebenniere tatsächlich eine Verteidigungsfunktion? Vol. 3. Organen International BV, Oss, the Netherlands.
26. MUNCK, A., P.M. GUYRE & N.J. HOLBROOK. 1984. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5: 25-44.
27. MEIJER, O.C. 2002. Coregulator proteins and corticosteroid action in the brain. J. Neuroendocrinol. 14: 499-505.
28. BAULIEU, E.E. 2000. "New" active steroids and an unforeseen mechanism of action. C. R. Acad. Sci. III 323: 513-518.
29. JOËLS, M. & E.R. DE KLOET. 1989. Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245: 1502-1505.
30. JOËLS, M. & E.R. DE KLOET. 1992. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15: 25-30.
31. JOËLS, M. & E.R. DE KLOET. 1994. Mineralocorticoid and glucocorticoid receptors in the brain: Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43: 1-36.
32. JOËLS, M. 1997. Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinol. 18: 2-48.
33. JOËLS, M. 2001. Corticosteroid actions in the hippocampus. J. Neuroendocrinol. 13: 657-669.
34. DIAMOND, D.M., M.C. BENNETT, K.E. STEVENS, et al. 1990. Exposure to a novel environment interferes with the induction of hippocampal primed burst potentiation in the behaving rat. Psychobiology 18: 273-286.
35. RATKA, A., W. SUTANTO, M. BLOEMERS, et al. 1989. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50: 117-123.
36. VAN HAARST, A.D., M.S. OITZL & E.R. DE KLOET. 1997. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem. Res. 22: 1323-1328.
37. DE KLOET, E.R., S. DE KOCK, V. SCHILD, et al. 1988. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamo-pituitary-adrenal axis at different brain sites. Neuroendocrinology 47: 109-115.
38. OITZL, M.S., A.D. VAN HAARST, W. SUTANTO, et al. 1995. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20: 655-675.
39. VAN HAARST, A.D., M.S. OITZL, J.O. WORKEL, et al. 1996. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137: 4935-4943.
40. PALKOVITS, M. 1999. Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Front. Neuroendocrinol. 20: 270-295.
41. COLE, R.L. & P.E. SAWCHENKO. 2002. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J. Neurosci. 22: 959-969.
42. HERMAN, J.P., W.E. CULLINAN, D.R. ZIEGLER, et al. 2002. Role of paraventricular microenvironment in stress integration. Eur. J. Neurosci. 16: 381-385.
43. HERMAN, J.P. & W.E. CULLINAN. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20: 78-84.
44. PACAK, K. & M. PALKOVITS. 2001. Stressor specificity of central neuroenodcrine responses: implications for stress-related disorders. Endocr. Rev. 22: 502-548.
45. ROMERO, L.M. & R.M. SAPOLSKY. 1996. Patterns of ACTH secretagog secretion in response to psychological stimuli. J. Neuroendocrinol. 8: 243-258.
46. KOVÁCS, K.J., A. FOLDES & P.E. SAWCHENKO. 2000. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurons. J. Neurosci. 15: 3843-3852.
47. DE KLOET, E.R., E. VREUGDENHIL, M.S. OITZL, et al. 1998. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19: 269-301.
48. WINDLE, R.J., S.A. WOOD, S.L. LIGHTMAN, et al. 1998. The pulsatile characteristics of the hypothalamo-pituitary-adrenal activity ion Lewis and Fisher 344 rats and its relationship to different stress responses. Endocrinology 139: 4044-4052.
49. LAUGERO, K.D., M.E. BELL, S. BHATNAGAR, et al. 2001. Sucrose ingestion normalizes central expression of corticotrophin releasing factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis? Endocrinology 142: 2796-2804.
50. AKANA, S.F., A. CHU, L. SORIANA, et al. 2001. Corticosterone exerts site specific and state dependent effects in prefrontal cortex and amygdala on regulation of adrenocorticotropic hormone, insulin and fat depots. J. Neuroendocr. 13: 625-637.
51. VAN DEN BUUSE, M., S.A. VAN ACKER, M.F. FLUTTERT, et al. 2002. Involvement of corticosterone in cardiovascular responses to an open-field novelty stressor in freely moving rats. Physiol. Behav. 75: 207-215.
52. KORTE, S.M. 2001. Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci. Biobehav. Rev. 25: 117-142.
53. HALLER, J., S. MILLAR, J. VAN DE SCHRAAF, et al. 2000. The active phase-related increase in corticosterone and aggression are linked. J. Neuroendocrinol. 12: 431-436.
54. OITZL, M.S., M. FLUTTERT & E.R. DE KLOET. 1994. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors. Eur. J. Neurosci. 6: 1072-1079.
55. OITZL, M.S. & E.R. DE KLOET. 1992. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106: 62-71.
56. SANDI, C., M. LOSCERTALES & C. GUAZA. 1997. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur. J. Neurosci. 9: 637-642.
57. DE KLOET, E.R., M.S. OITZL & M. JOËLS. 1999. Stress and cognition: are corticosteroids good or bad guys? Trends Neurosci. 22: 422-426.
58. ROOZENDAAL, B. 2000. 1999-Curt P. Richter Award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25: 213-238.
59. MCGAUGH, J.L. & B. ROOZENDAAL. 2002. Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 12: 205-210.
60. OITZL, M.S., H.M. REICHARDT, M. JOËLS, et al. 2001. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc. Natl. Acad. Sci. USA 98: 12790-12795.
61. KARST, H., Y.J, KARTEN, H.M. REICHARDT, et al. 2000. Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat. Neurosci. 3: 977-978.
62. REICHARDT, H.M., F. TRONCHE, S. BERGER, et al. 2000. New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. Adv. Pharmacol. 47: 1-21.
63. OITZL, M.S., M. FLUTTERT, W. SUTANTO, et al. 1998. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur. J. Neurosci. 10: 3759-3766.
64. HOLSBOER, F. 2003. Corticotropin-releasing hormone modulators and depression. Curr. Opin. Invest. Drugs 4: 46-50.
65. HAUGER, R.L., D.E. GRIGORIADIS, M.F. DALLMAN, et al. 2003. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin releasing factor and their ligands. Pharmacol. Rev. 55: 21-26.
66. HSU, S.Y. & A.J. HSUEH. 2001. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7: 605-611.
67. REUL, J.M. & F. HOLSBOER. 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2: 23-33.
68. LEWIS, K., C. LI, M.H. PERRIN, et al. 2001. Identification of urocortin III, an additional member of the corticotropin releasing factor (CRF) family with high affinity for the CRH 2 receptor. Proc. Natl. Acad. Sci. USA 8: 7570-7575.
69. LI, C., J. VAUGHAN, P.E. SAWCHECKO, et al. 2002. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotropin-releasing factor receptor expression. J. Neurosci. 22: 991-1001.
70. MCEWEN, B.S. & J.C. WINGFIELD. 2003. The concept of allostasis in biology and biomedicine. Horm. Behav. 43: 2-15.
71. LANDGRAF, R. & A. WIGGER. 2002. High vs low anxiety-related behaviour in rats: an animal model of extremes in trait anxiety. Behav. Genet. 32: 301-314.
72. Bohus, B., R.F. BENUS, D.S. FOKKEMA, et al. 1987. Neuroendocrine states and behavioural and physiological stress responses. Progr. Brain Res. 72: 57-70.
73. VEENEMA, A.H., O.C. MEIJER, E.R. DE KLOET, et al. 2003. Differences in basal and stress-induced HPA regulation of wild house mice selected for high and low aggression. Horm. Behav. 43: 197-204.
74. VEENEMA, A.H., O.C. MEIJER, E.R. DE KLOET, et al. 2003. Genetic selection for coping style predicts stressor susceptibility. J. Neuroendocrinol. 12: 256-267.
75. CARTER, C.S. 1998. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinolgy 23: 779-818.
76. MCEWEN, B.S. 2002. Protective and damaging effects of stress mediators: the good and bad sides of the response to stress. J. Clin. Endocr. Metab. 51: 2-4.
77. SAPOLSKY, R.M. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psych. 57: 925-935.
78. CZEH, B., T. MICHAELIS, T. WATANABE, et al. 2001. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA 98: 12796-12801.
79. DE RIJK, R.H., M.J. SCHAAF, G. TURNER, et al. 2001. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28: 2383-2388.
80. VAN ROSSUM, E.F., J.W. KOPER, N.A. HUIZENGA, et al. 2002. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51: 3128-3134.
81. LANDGRAF, R.M. & A. WIGGER. 2003. Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats. Stress 6: 111-119.
82. DATSON, N.A., J. VAN DER PERK, E.R. DE KLOET, et al. 2001. Identification of corticosteroid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur. J. Neurosci. 14: 675-689.
83. FELDKER, D.E.M., N.A. DATSON, A.H. VEENEMA, et al. 2003. Serial analysis of gene expression predicts structural differences in hippocampus of long attack latency and short attack latency mice. Eur. J. Neurosci. 17: 379-387.
84. FELDKER, D.E.M., N.A. DATSON, A.H. VEENEMA, et al. 2004. Gene chips analysis of hippocampal gene expression profiles of short and long attack legacy mice: technical and biological implications. J. Neurosci. Res. 74: 701-716.